The Petco-backed pet services provider is set to be valued at about $1.6bn in a deal that will involve it listing on the Nasdaq Capital Market.

The past week's M&A exits included Genetirate, DataFleets and SightGlass Vision.

The medical documentation tool developer has been acquired by Nuance Communications having raised $7.5m from investors including NewYork-Presbyterian.

Bloomberg Beta and GV are set to exit the data analytics technology developer in a $155m transaction that will follow about $33m in funding.

Adways, Fidelity, Nissay Capital, Opt, SMBC Venture Capital and Voyage Ventures are all set to exit the C2C skills marketplace operator in an offering on TSE’s Mothers Market.

The CBRE, Ericsson, AMD, News Corp, PTC and Qualcomm-backed spatial modelling technology provider will list on the Nasdaq Capital Market through the deal.

Total is set to score an exit from the fuel cell vehicle developer just four months on from its investment, through a reverse merger that will value Hyzon at $2.1bn once the deal closes.

SoftBank will exit social video app developer Hyperconnect roughly six years after it took part in an $8.6m series A round.

The share price of Columbia University's cellular oncology drug developer, backed by Osage University Partners, has doubled since it floated.

The share price of the cellular oncology drug developer, which counts Novartis, Johnson & Johnson and PureTech Health as investors, has doubled since it floated.